1572 related articles for article (PubMed ID: 22661461)
1. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
2. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
3. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
Sharma N; Rao SS; Reddy AM
J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
[TBL] [Abstract][Full Text] [Related]
4. A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms.
Rao DD; Satyanarayana NV; Malleswara Reddy A; Sait SS; Chakole D; Mukkanti K
J Pharm Biomed Anal; 2010 Feb; 51(3):736-42. PubMed ID: 19815361
[TBL] [Abstract][Full Text] [Related]
5. A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets.
Nalwade SU; Reddy VR; Rao DD; Morisetti NK
J Pharm Biomed Anal; 2012 Jan; 57():109-14. PubMed ID: 21920688
[TBL] [Abstract][Full Text] [Related]
6. Stability-indicating UPLC method for determining related substances and degradants in dronedarone.
Pydimarry SP; Cholleti VK; Vangala RR
J Chromatogr Sci; 2014 Aug; 52(7):666-75. PubMed ID: 23863770
[TBL] [Abstract][Full Text] [Related]
7. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
Azougagh M; Elkarbane M; Bakhous K; Issmaili S; Skalli A; Iben Moussad S; Benaji B
Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
[TBL] [Abstract][Full Text] [Related]
8. Quantification of halobetasol propionate and its impurities present in topical dosage forms by stability-indicating LC method.
Nalwade S; Reddy VR; Kulkarni D; Todamal S
J Chromatogr Sci; 2015 Jan; 53(1):127-34. PubMed ID: 24784115
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a stability-indicating RP-LC method for famciclovir.
Raman NV; Harikrishna KA; Prasad AV; Ratnakar Reddy K; Ramakrishna K
J Pharm Biomed Anal; 2009 Dec; 50(5):797-802. PubMed ID: 19632799
[TBL] [Abstract][Full Text] [Related]
11. A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection.
Jagadabi V; Nagendra Kumar PV; Mahesh K; Pamidi S; Ramaprasad LA; Nagaraju D
J Chromatogr Sci; 2019 Jan; 57(1):44-53. PubMed ID: 30169761
[TBL] [Abstract][Full Text] [Related]
12. Analysis of duloxetine hydrochloride and its related compounds in pharmaceutical dosage forms and in vitro dissolution studies by stability indicating UPLC.
Rao DD; Sait SS; Reddy AM; Chakole D; Reddy YR; Mukkanti K
J Chromatogr Sci; 2010 Nov; 48(10):819-24. PubMed ID: 21044412
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
Reddy PS; Sudhakar Babu K; Kumar N
J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
[TBL] [Abstract][Full Text] [Related]
14. Stability indicating LC method for rapid determination of related substances of O-desmethyl venlafaxine in active pharmaceutical ingredients and pharmaceutical formulations.
Rao KV; Reddy KP; Kumar YR
J Chromatogr Sci; 2014; 52(10):1247-54. PubMed ID: 24474426
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Impurities in Cinacalcet Hydrochloride API and its Formulation.
Sunil Reddy P; Raju TV; Raju PS; Varma NS; Babu KS
Sci Pharm; 2015; 83(4):583-98. PubMed ID: 26839840
[TBL] [Abstract][Full Text] [Related]
16. A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms.
Rao PV; Kumar MN; Kumar MR
Sci Pharm; 2013; 81(1):183-93. PubMed ID: 23641337
[TBL] [Abstract][Full Text] [Related]
17. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Nageswari A; Reddy KV; Mukkanti K
J Pharm Biomed Anal; 2012 Jul; 66():109-15. PubMed ID: 22502910
[TBL] [Abstract][Full Text] [Related]
18. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms.
Krishnaiah Ch; Vishnu Murthy M; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2011 Mar; 54(4):667-73. PubMed ID: 21075576
[TBL] [Abstract][Full Text] [Related]
19. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
Vijayabaskar S; Mahalingam V; Kalaivani
J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
[TBL] [Abstract][Full Text] [Related]
20. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
